The medication targets the glucagon-like peptide-1 receptor (GLP-1R) to help reduce appetite, slow gastric emptying, and improve insulin secretion
The most common ones are: Nausea, queasiness, or a "too full" feeling
The chat was handed off to a human quickly when we asked
BPC-157: Known for its regenerative properties, BPC-157 promotes tissue healing and reduces inflammation, which can indirectly aid in fat loss by enhancing recovery and supporting an active lifestyle
To provide the right care for patients taking GLP-1s, physical therapists and care teams must be versed on the impact that obesity and diabetes have on the entire MSK system, particularly diminished tendon health, impaired muscle function and joint degradation